PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
1999 | 04 | 4 |

Tytuł artykułu

Biophysical characterisation of liposomal delivery systems for lipophilic drugs: cyclosporin A as an example

Autorzy

Warianty tytułu

Języki publikacji

EN

Abstrakty

EN
Liposomal formulations of cyclosporin A have been investigated in a series of studies. One of the most used arguments for the development of this pharmaceutical preparation was the high lipophilicity of cyclosporin A, which ensures an encapsulation of cyclosporin A in the liposomal bilayer. From this study on the interaction of cyclosporin with lipids spread as a monolayer on the air/water interface we demonstrate, that one molecule of cyclosporin A occupies an area of 260 Å2 in the lipid monolayer. These data correlate well with molecular modelling data, calculating a cross-sectional area of 230 Å2 for a cyclosporin A molecule. Calculation of a partition coefficient using these data at different surface pressures results in a value of about 4000 at a surface pressure of about 31 mN/m. This partition coefficient is also found in bilayer membranes supporting the notion, that phospholipid bilayer systems have a surface pressure of about 32 mN/m. If the lipid:cyclosporin A ratio exceeds a value of 20, the lipid monolayer becomes nonlinear. Cyclosporin A starts to detoriate liposomal membranes at similar lipid:cyclosporin ratios. It could also be concluded from our measurements at the air/water interface, that cyclosporin A is able to exchange binding places between membranes rapidly with a time constant of about 2.5 min. Lipid monolayer experiments are not only an easy and fast method to obtain information about molecule interactions with lipid membranes, but is also a suitable method to develop liposomal formulations of drugs.

Wydawca

-

Rocznik

Tom

04

Numer

4

Opis fizyczny

p.611-623,fig.

Twórcy

autor
  • University Marburg, Ketzerbach 63, D-35032 Marburg, Germany
autor

Bibliografia

  • 1. Fahr, A., Nimmerfall, F. and Wenger, R. Interactions of Cyclosporin A and some derivatives with model membranes: Binding and ion permeability changes. Transplant. Proc. 26 (1994) 2837-2841.
  • 2. Fahr, A., Holz, M. and Fricker, G. Liposomal formulations of Cyclosporin A: Influence of lipid type and dose on pharmacokinetics. Pharm Res. 12 (1995) 1189-1198.
  • 3. Thiel, G., Hermle, M. and Brunner, F. P. Acutely impaired renal function during intravenous administration of cyclosporine A: a cremophor side-effect. Clin. Nephrol. 25 (1986) S40-S42.
  • 4. Fromherz, P. Instrumentation for handling monomolecular films at an air-water interface. Rev. Sci. Instrum. 46 (1975) 1380-1385.
  • 5. MacDonald, R. C., MacDonald, R. I., Takeshita, K., Subbarao, N. K. and Hu, L. R. Small-volume extrusion apparatus for preparation of large, unilamellar vesicles. Biochim. Biophys. Acta 1061 (1991) 297-303.
  • 6. Ruf, H., Y. Georgalis, and E. Grell, Dynamic laser light scattering to dertermine size distributions of vesicles. Meth. Enzymol. 172 (1989) 364- 390.
  • 7. Bar, R. S., D. W. Deamer, and D. G. Cornwell, Surface area of human erythrocyte lipids: reinvestigation of experiments on plasma membrane. Science 153 (1966) 1010-1012.
  • 8. Wiedmann, T. S. and K. R. Jordan, Interaction of Cyclosporin A with dipalmitoylphosphatidylcholine at the air/water interface. Langmuir 7 (1991) 318-322.
  • 9. Lorenz, R. G., Garrett, N., Turk, J. W. and Scott, M. G. Problems with therapeutic monitoring of cyclosporine using silicone central venous line samples. Transplantation 52 (1991) 1109-1110.
  • 10. Seelig, A., Local anesthetics and pressure: a comparison of dibucaine binding to lipid monolayers and bilayers. Biochim. Biophys. Acta 899 (1987) 196-204.
  • 11. Soderlund, T., J. Y. A. Lehtonen, and P. K. J. Kinunnen, Interactions of cyclosporin A with phospholipid membranes: effect of cholesterol. Mol. Pharmacol. 55 (1999) 32-38.
  • 12. Demel, R. A., Geurts van Kessel, W. S., Zwaal, R. F., Roelofsen, B. and van Deenen, L. L. M. Relation between various phospholipase actions on human red cell membranes and the interfacial phospholipid pressure in monolayers. Biochim. Biophys. Acta 406 (1975) 97-107.
  • 13. Cefalu, W. T. and W. M. Pardridge, Restrictive transport of a lipid-soluble peptide (cyclosporine) through the blood-brain barrier. J. Neurochem. 45 (1985) 1954-1956.
  • 14. Tsuji, A., Tamai, I., Sakata, A., Tenda, Y. and Terasaki, T. Restricted transport of cyclosporin A across the blood-brain barrier by a multidrug transporter, P-glycoprotein. Biochem. Pharmacol. 46 (1993) 1096-1099.

Typ dokumentu

Bibliografia

Identyfikatory

Identyfikator YADDA

bwmeta1.element.agro-article-29f3e94c-060b-41fd-ae97-7b754429d316
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.